Evidence map›Paper›PMID 27057892›Full record

Observational studyMedicine2016

Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.

Pei-Ju Liao, Tzu-Yu Lin, Tzu-Ching Wang, Ming-Kuo Ting, I-Wen Wu, Hsin-Tsung Huang, Fu-Chung Wang, Huan-Cheng Chang, Kuang-Hung Hsu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Pei-Ju LiaoFrom the Department of Health Care Administration, Oriental Institute of Technology, New Taipei City (P-JL); Healthy Aging Research Center, Chang Gung University, Taoyuan (T-YL, K-HH); National Health Insurance Administration, Ministry of Health and Welfare, Taipei (T-CW, H-TH, F-CW); Department of Medicine, College of Medicine, Chang Gung University, Taoyuan (I-WW); Division of Endocrinology and Metabolism (M-KT); Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung (I-WW); Division of Nephrology, Department of Medicine, Taiwan Landseed Hospital (H-CC); and Department of Health Care Management, Chang Gung University, Taoyuan, Taiwan (H-CC, K-HH).
Tzu-Yu Lin
Tzu-Ching Wang
Ming-Kuo Ting
I-Wen Wu
Hsin-Tsung Huang
Fu-Chung Wang
Huan-Cheng Chang
Kuang-Hung Hsu
Maine Farmland Trust · USChang Gung University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined.This study is a retrospective population-based patient cohort design to examine the continuous effects of diabetes and CKD P4P interventions. This study used the health insurance claims database to conduct a longitudinal analysis. A total of 32,084 early CKD patients with diabetes were extracted from the outpatient claims database from January 2011 to December 2012, and the follow-up period was extended to August 2014. A 4-group matching design, including both diabetes and early CKD P4P interventions, with only diabetes P4P intervention, with only early CKD P4P intervention, and without any P4P interventions, was performed according to their descending intensity. The primary outcome of this study was all-cause mortality and the causes of death. The statistical methods included a Chi-squared test, ANOVA, and multi-variable Cox regression models.A dose-response relationship between the intervention groups and all-cause mortality was observed as follows: comparing to both diabetes and early CKD P4P interventions (reference), hazard ratio (HR) was 1.22 (95% confidence interval [CI], 1.00-1.50) for patients with only a diabetes P4P intervention; HR was 2.00 (95% CI, 1.66-2.42) for patients with only an early CKD P4P intervention; and HR was 2.42 (95% CI, 2.02-2.91) for patients without any P4P interventions. The leading cause of death of the total diabetic nephropathy patient cohort was infectious diseases (34.32%) followed by cardiovascular diseases (17.12%), acute renal failure (1.50%), and malignant neoplasm of liver (1.40%).Because the earlier interventions have lasting long-term effects on the patient's prognosis regardless of disease course, an integrated early intervention plan is suggested in future care plan designs. The mechanisms regarding the effects of P4P intervention, such as health education on diet control, continuity of care, and practice guidelines and adherence, are the primary components of disease management programs.

Indexed as

Disease ProgressionEarly Medical InterventionReimbursement, IncentiveAgedDiabetic NephropathiesFemaleHumansMaleMiddle AgedRenal Insufficiency, ChronicRetrospective StudiesSeverity of Illness IndexTime Factors

Identifiers

PMID27057892
PMCPMC4998808
OpenAlexW2340239619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.